Ace Blend Raises USD 9.91 Mn Series A2 Led by 3one4 Capital
Ace Blend raises USD 9.9 million Series A2 led by 3one4 Capital as Fireside Ventures doubles down on the nutrition brand.
Shivam Hingorani, Founder and Chief Vision Officer, Ace Blend
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Ace Blend, a science-led nutrition company, has raised USD 9.91 million in a Series A2 round led by 3one4 Capital, with existing investor Fireside Ventures increasing its investment. Fireside had led Ace Blend’s USD 3.3 million pre-Series A round. The company grew 300% in FY26.
“The human body is one of the most sophisticated machines on earth, but it evolves over thousands of years. The world around us is accelerating far faster than our biology can keep up. That gap is where so many modern deficiencies and diseases live. Our work is to close it,” said Shivam Hingorani, Founder and Chief Vision Officer, Ace Blend.
The funds will go toward bringing new nutrition formats to market, the first of which is due in Q4 FY27, and continued investment in research-led product development. Ace Blend says it has created entirely new formats of nutrition designed to fit into everyday life, and holds issued patents on them. Its other focus is upgrading familiar nutrients with more bioavailable forms. The products span heart health, immunity, sleep, recovery and brain health.
Unlike brands that choose a popular ingredient and cite existing studies, Ace Blend says it starts with clinical evidence, which sets the nutrient form, the dose used in research and the delivery method. It also manufactures what it sells instead of using contract manufacturers, controlling quality from sourcing to formulation and manufacturing.
Clinical validation and automated testing are handled by accredited labs in Europe. DSM and TCI have given the company exclusive rights in India to technologies they have developed, and its products are recommended by more than 400 doctors.
“In a crowded category where low-moat brands behave like traders and compete only on marketing, Ace is scaling science-led formulations and a trust-first approach with rigorous focus on ingredient quality, sourcing discipline, and manufacturing specialisation,” said Pranav Pai, Managing Partner, 3one4 Capital.
Ace Blend, a science-led nutrition company, has raised USD 9.91 million in a Series A2 round led by 3one4 Capital, with existing investor Fireside Ventures increasing its investment. Fireside had led Ace Blend’s USD 3.3 million pre-Series A round. The company grew 300% in FY26.
“The human body is one of the most sophisticated machines on earth, but it evolves over thousands of years. The world around us is accelerating far faster than our biology can keep up. That gap is where so many modern deficiencies and diseases live. Our work is to close it,” said Shivam Hingorani, Founder and Chief Vision Officer, Ace Blend.
The funds will go toward bringing new nutrition formats to market, the first of which is due in Q4 FY27, and continued investment in research-led product development. Ace Blend says it has created entirely new formats of nutrition designed to fit into everyday life, and holds issued patents on them. Its other focus is upgrading familiar nutrients with more bioavailable forms. The products span heart health, immunity, sleep, recovery and brain health.
Entrepreneur Staff • Editor
Entrepreneur Staff
For more than 30 years, Entrepreneur has set the course for success for millions of... Read more
